Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rohane

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Diabetes|January 1, 1996
Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouseA Shimada, P Rohane, C G Fathman, et al.
Journal of Autoimmunity|April 1, 1996
Immune regulation in type 1 diabetesA Shimada, B Charlton, P Rohane, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 4, 2012
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison studyK A Papp, R Kaufmann, D Thaçi, et al.
Pediatrics|August 3, 2001
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)H Milgrom, W Berger, A Nayak, et al.
Current Medical Research and Opinion|April 19, 2008
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilastA B Gottlieb, B Strober, J G Krueger, et al.
Clinical Pharmacology and Therapeutics|January 20, 1998
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitisA Racine-Poon, L Botta, T W Chang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Diabetes|January 1, 1996
Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouseA Shimada, P Rohane, C G Fathman, et al.
Journal of Autoimmunity|April 1, 1996
Immune regulation in type 1 diabetesA Shimada, B Charlton, P Rohane, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 4, 2012
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison studyK A Papp, R Kaufmann, D Thaçi, et al.
Pediatrics|August 3, 2001
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)H Milgrom, W Berger, A Nayak, et al.
Current Medical Research and Opinion|April 19, 2008
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilastA B Gottlieb, B Strober, J G Krueger, et al.
Clinical Pharmacology and Therapeutics|January 20, 1998
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitisA Racine-Poon, L Botta, T W Chang, et al.
Pageof 1